Table 4. Combined summary data for clinical trials with liraglutide.

Only highest doses from these trials are shown. MET: metformin. FPG: fasting plasma glucose. NR: not reported. 1 Fraction of patients (in %) with HbA1c ≤ 7% at the end of the study. 2 Fraction of patients with adverse effects (in %). a Placebo-subtracted change. b Change vs. MET monotherapy.